Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CTSG | P08311 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29165376 | 0.77 | ALDH1A1 (0.36) | ALDH1A1MAPTMGLLGAATHRB | |
| SCHEMBL10646550 | 0.75 | — | — | |
| SCHEMBL20544702 | 0.73 | GAA (0.42) | ALDH1A1MAPTMGLLSMN1; SMN2GAA | |
| SCHEMBL515520 | 0.71 | ALDH1A1 (0.50) | ALDH1A1MAPTMGLLGAATHRB | |
| SCHEMBL26721606 | 0.71 | F2 (0.35) | F2ELANECTSGCTRCALDH1A1 | |
| Hydrochloric Acid SCHEMBL8590266 | 0.69 | F2 (0.60) | F2ELANECTSGCTRCALDH1A1 | |
| SCHEMBL3831786 | 0.69 | F2 (0.60) | F2ELANECTSGCTRCALDH1A1 | |
| SCHEMBL21996053 | 0.69 | F2 (0.60) | F2ELANECTSGCTRCALDH1A1 | |
| SCHEMBL8613982 | 0.67 | CA12 (0.34) | F2ELANECTSGCTRC | |
| SCHEMBL1033205 | 0.67 | F2 (0.43) | F2ELANECTSGCTRCALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714928-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A HETEROCYCLIC COMPOUND COMPRISING AT LEAST ONE N-N SINGLE BOND | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| CN-120202258-A | Compositions and methods for reducing formaldehyde in acrylic or styrene-acrylic polymer products | 陶氏环球技术有限责任公司 | 2025-06-24 | — | — | CN | claimed |
| CN-117651546-A | Oxidation retardant composition | 莱雅公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117615746-A | Dye set | 莱雅公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117597104-A | Combination for dyeing keratin fibres and use thereof | 莱雅公司 | 2024-02-23 | — | — | CN | claimed |
| WO-2023272863-A1 | COMBINATION FOR DYEING KERATIN FIBERS AND USE THEREOF | L'OREAL (FR) | 2023-01-05 | — | — | WO | claimed |
| WO-2023272588-A1 | RETARDANT COMPOSITION OF OXIDATION | L'OREAL (FR) | 2023-01-05 | — | — | WO | claimed |
| WO-2023272610-A1 | DYE KIT | L'OREAL (FR) | 2023-01-05 | — | — | WO | claimed |
| EP-1002520-B1 | Composition for oxidative dying of keratinous fibres and dying process therewith | OREAL (FR) | 2008-10-29 | — | — | EP | claimed |
| US-7179301-B2 | Dyeing compositions for keratinous fibers containing paraphenylenediamine derivatives with pyrrolidinyl group | L'OREAL S.A. (FR) | 2007-02-20 | — | — | US | claimed |
| US-6890362-B2 | Oxidation dyeing composition for keratinous fibers and dyeing method using same | L'OREAL, S.A. (FR) | 2005-05-10 | — | — | US | claimed |
| EP-0988021-B1 | KERATIN FIBRE OXIDATION DYEING COMPOSITION AND DYEING METHOD USING SAME | OREAL (FR) | 2003-11-12 | — | — | EP | claimed |
| US-6551360-B2 | Pyrazoline-3,5-dione-containing compositions for dyeing keratin fibres; their use in dyeing as couplers; dyeing process | VIDAL LAURENT (FR) | 2003-04-22 | — | — | US | claimed |
| US-20030009835-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | L'OREAL S.A. (FR) | 2003-01-16 | — | — | US | claimed |
| US-6395042-B1 | OXIDATION BASE, HETEROCYCLIC COUPLERS FOR OXIDATION COLOR DYE | L'ORÉAL (FR) | 2002-05-28 | — | — | US | claimed |
| EP-0900074-B1 | KERATIN FIBRE DYE COMPOSITIONS CONTAINING PYRAZOLIN-3,5-DIONE COMPOUNDS, USE THEREOF AS DYE COUPLERS, AND DYEING METHOD | OREAL (FR) | 2002-05-15 | — | — | EP | claimed |
| US-20010054205-A1 | Pyrazoline-3, 5-dione-containing compositions for dyeing keratin fibres; their use in dyeing as couplers; dyeing process | L'OREAL | 2001-12-27 | — | — | US | claimed |
| EP-1047381-A1 | KERATINOUS FIBRE OXIDATION DYEING COMPOSITION CONTAINING A LACCASE AND DYEING METHOD USING SAME | L'OREAL (FR) | 2000-11-02 | — | — | EP | claimed |
| EP-1002520-A1 | Composition for oxidative dying of keratinous fibres and dying process therewith | L'OREAL (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999036039-A1 | KERATINOUS FIBRE OXIDATION DYEING COMPOSITION CONTAINING A LACCASE AND DYEING METHOD USING SAME | L'OREAL (FR) | 1999-07-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010054205-A1 | Pyrazoline-3, 5-dione-containing compositions for dyeing keratin fibres; their use in dyeing as couplers; dyeing process | KRT18, PYCR1, COX5A | F2 760/4885ELANE 4241/4885CTSG 3875/4885 |
| US-20030009835-A1 | Oxidation dyeing composition for keratinous fibres and dyeing method using same | KRT18, PPOX, NDUFB5 | F2 2354/4885ELANE 3371/4885CTSG 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.